|
| |
DRLOur company, as a member of Daiichi Seiyaku ( Daiichi Pharmaceutical Co., Ltd. ) Group and since its foundation in 1968, has devoted itself to the research, development,manufacture and sale of superior new radiopharmaceutical products, and has greatly contributed to the improvement of the public health and welfare as well as the progress of the nuclear medicine in Japan. The nuclear medicine has made a remarkable progress over quarter a century since the first use of radioisotope into a human being.
Today, the nuclear medicine can detect biochemical state of brain in mental disease, dementia etc. in the form of an image and has also come to be able to catch various states of diseases such as cardiovascular disorders that were difficult to do so with other diagnostic modalities.
A great number of radiopharmaceuticals have largely contributed to the decision-making for diagnosis and treatment of various diseases.Now,as the advent of the 21st century the future of nuclear medicine extends immeasurablyOur company is proud of being a total healthcare maker playing a part in the development of nuclear medicine examination and has been continuing the research and development activities searching further a new possibility employing the state of art technologies for health today and tomorrow.
| Contact Details: |
| 17-10, kyobashi 1-Chome |
| Chuo-Ku |
| Tokyo |
| 104-0031 |
| Japan |
| Tel: | 81-3-5250-2600 |
| Fax: | |
| Email: | gad@drl.co.jp |
| WWW: | www.drl.co.jp/
|
| |
Recent Publications by DRL: |  |
Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells.
AIMS/HYPOTHESIS: The aim of this study was to characterise electrical... | 24th October, 2009
| Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill
| Diabetologia. 2009 Aug;52(8):1566-78. Epub 2009 May 14.
DOI Direct Link |
Diabetes in post genomic era: promises to discover biomarkers and new drug targets.
The complementary disciplines of genomics and proteomics offer better... | 21st August, 2009
| Department of Physiology, Ibrahim Medical College, 122 Kazi Nazrul Islam
| Mymensingh Med J. 2008 Jul;17(2 Suppl):S111-5.
|
What will genome-wide association studies mean to the clinical endocrinologist?
AIMS/HYPOTHESIS: The aim of this study was to characterise electrical... | 7th August, 2009
| Oxford Centre for Diabetes, Endocrinology and Metabolism, University of
| J Clin Endocrinol Metab. 2009 Jul;94(7):2245-6. Epub 2009 May 5.
DOI Direct Link |
Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery.
ABSTRACT : Identification of common-variant associations for many common... | 14th July, 2009
| Oxford Centre for Diabetes, Endocrinology & Metabolism, University of
| Genome Med. 2009 Jul 3;1(7):66.
DOI Direct Link |
Genome-wide association studies in type 2 diabetes.
Despite numerous candidate gene and linkage studies, the field of type 2... | 9th July, 2009
| Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill
| Curr Diab Rep. 2009 Apr;9(2):164-71.
|
→View more DRL research publications. |
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 11 individuals from DRL using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 320 times since April 2007, the link to the organisation's website has been followed 55 times Search for more companies in Chuo-Ku Search for more companies in Tokyo This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for DRL |
